Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 32.92%13.43B | 9.89%10.1B | -7.60%2.27B | 38.89%3.22B | -12.27%1.77B | 18.50%2.84B | 29.84%9.19B | 19.07%2.46B | 22.40%2.32B | 28.73%2.02B |
| Cost of revenue | -32.46%129M | -33.91%191M | -28.57%50M | -38.46%48M | -46.05%41M | -20.00%52M | -43.11%289M | -56.79%70M | -44.29%78M | -31.53%76M |
| Gross profit | 34.17%13.3B | 11.31%9.91B | -6.91%2.22B | 41.49%3.17B | -10.90%1.73B | 19.51%2.79B | 35.48%8.91B | 25.47%2.39B | 27.72%2.24B | 33.31%1.95B |
| Operating expense | 21.24%6.66B | 6.49%5.5B | 13.85%1.58B | -1.79%1.26B | 15.47%1.46B | -2.46%1.19B | 22.92%5.16B | 12.05%1.39B | 32.44%1.29B | 25.69%1.27B |
| Staff costs | 32.09%3.01B | 21.01%2.28B | 26.19%742M | 21.38%494M | 18.11%561M | 16.59%478M | 28.59%1.88B | 25.91%588M | 33.88%407M | 32.31%475M |
| Selling and administrative expenses | -20.73%65M | 10.81%82M | 21.05%23M | 5.88%18M | -30.43%16M | 66.67%25M | 15.63%74M | 18.75%19M | 0.00%17M | 53.33%23M |
| -General and administrative expense | -20.73%65M | 10.81%82M | 21.05%23M | 5.88%18M | -30.43%16M | 66.67%25M | 15.63%74M | 18.75%19M | 0.00%17M | 53.33%23M |
| Depreciation and amortization | 13.41%372M | 31.20%328M | 16.22%86M | 50.00%90M | 44.83%84M | 17.24%68M | 15.21%250M | 21.31%74M | 13.21%60M | 9.43%58M |
| -Depreciation | 13.41%372M | 31.20%328M | 16.22%86M | 50.00%90M | 44.83%84M | 17.24%68M | 15.21%250M | 21.31%74M | 13.21%60M | 9.43%58M |
| Rent and land expenses | -0.43%689M | 17.69%692M | -9.29%166M | 0.00%163M | 33.59%175M | 69.37%188M | 25.11%588M | 67.89%183M | 45.54%163M | 6.50%131M |
| Other operating expenses | 19.50%2.53B | -10.56%2.12B | 7.47%561M | -22.07%498M | 8.10%627M | -31.10%432M | 19.29%2.37B | -10.62%522M | 31.75%639M | 26.64%580M |
| Operating profit | 50.26%6.64B | 17.94%4.42B | -35.59%646M | 99.90%1.91B | -60.18%270M | 43.65%1.6B | 57.68%3.75B | 50.37%1B | 21.87%953M | 50.33%678M |
| Net non-operating interest income (expenses) | 33.33%-8M | 0.00%-12M | -33.33%-4M | 33.33%-2M | 0.00%-3M | 0.00%-3M | -500.00%-12M | 25.00%-3M | -50.00%-3M | -160.00%-3M |
| Non-operating interest income | -50.00%1M | 100.00%2M | --0 | 100.00%2M | --0 | --0 | -90.91%1M | --0 | 0.00%1M | --0 |
| Non-operating interest expense | -35.71%9M | 7.69%14M | 33.33%4M | 0.00%4M | 0.00%3M | 0.00%3M | 0.00%13M | -25.00%3M | 33.33%4M | -25.00%3M |
| Net investment income | 192.86%13M | -180.00%-14M | -700.00%-8M | -50.00%5M | 0.00%-3M | 27.27%-8M | 68.75%-5M | 85.71%-1M | 350.00%10M | 0.00%-3M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | -59.70%27M | 13M | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 73.08%-7M | 79.37%-26M | 101.75%1M | 81.16%-13M | -7M | -7M | -173.91%-126M | -78.13%-57M | -69M | 0 |
| Less:Other special charges | -73.91%6M | -81.75%23M | -101.75%-1M | --7M | --7M | --10M | 293.75%126M | --57M | ---- | ---- |
| Less:Write off | -66.67%1M | --3M | --0 | --6M | --0 | ---3M | --0 | --0 | --0 | --0 |
| Other non-operating income (expenses) | 450.00%11M | -66.67%2M | 200.00%6M | 0.00%1M | -3M | -1M | ||||
| Income before tax | 52.36%6.64B | 20.11%4.36B | -33.47%636M | 110.43%1.9B | -62.00%255M | 42.74%1.57B | 52.71%3.63B | 52.96%956M | 5.75%901M | 51.13%671M |
| Income tax | 104.29%2.1B | 149.03%1.03B | 518.60%180M | 200.57%523M | -52.67%62M | 74.00%261M | 119.15%412M | -127.92%-43M | 75.76%174M | 627.78%131M |
| Net income | 36.35%4.55B | 3.64%3.33B | -54.21%457M | 88.46%1.37B | -64.26%193M | 37.96%1.31B | 46.96%3.22B | 111.44%998M | -3.19%728M | 27.06%540M |
| Net income continuous operations | 36.38%4.55B | 3.60%3.33B | -54.35%456M | 88.86%1.37B | -64.26%193M | 37.82%1.31B | 47.01%3.22B | 112.10%999M | -3.45%727M | 26.76%540M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Net income attributable to the company | 36.38%4.55B | 3.64%3.33B | -54.31%456M | 88.60%1.37B | -64.26%193M | 37.96%1.31B | 46.96%3.22B | 111.44%998M | -3.06%728M | 26.76%540M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 36.38%4.55B | 3.64%3.33B | -54.31%456M | 88.60%1.37B | -64.26%193M | 37.96%1.31B | 46.96%3.22B | 111.44%998M | -3.06%728M | 26.76%540M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 40.20%164.58 | 5.64%117.39 | -52.00%16.65 | 90.56%48.25 | -63.11%6.81 | 39.91%45.68 | 47.92%111.12 | 114.27%34.69 | -1.82%25.32 | 26.53%18.46 |
| Diluted earnings per share | 38.86%163.01 | 5.64%117.39 | -52.88%16.3455 | 90.56%48.25 | -63.25%6.7845 | 39.91%45.68 | 47.92%111.12 | 114.27%34.69 | -1.72%25.32 | 26.53%18.46 |
| Dividend per share | 33.33%32 | 41.18%24 | -5.88%16 | 0 | 8 | 0 | 54.55%17 | 54.55%17 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |